These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 1683871

  • 21. Protein kinase C activity and multidrug resistance in MOLT-3 human lymphoblastic leukemia cells resistant to trimetrexate.
    Schwartz GK, Arkin H, Holland JF, Ohnuma T.
    Cancer Res; 1991 Jan 01; 51(1):55-61. PubMed ID: 1824824
    [Abstract] [Full Text] [Related]

  • 22. Human lymphoblastoid cells with acquired resistance to C2-desamino-C2-methyl-N10-propargyl-5,8-dideazafolic acid: a novel folate-based thymidylate synthase inhibitor.
    O'Connor BM, Jackman AL, Crossley PH, Freemantle SE, Lunec J, Calvert AH.
    Cancer Res; 1992 Mar 01; 52(5):1137-43. PubMed ID: 1737372
    [Abstract] [Full Text] [Related]

  • 23. Microsatellite instability and clonal heterogeneity of MDR1 messenger RNA expression in trimetrexate-resistant human leukemia MOLT-3 cells developed in thymidine.
    Miyachi H, Ma L, Takemura Y, Kobayashi H, Hirahara I, Sonehara H, Ando Y.
    Int J Cancer; 1999 Jul 02; 82(1):63-9. PubMed ID: 10360822
    [Abstract] [Full Text] [Related]

  • 24. Cross-resistance studies of folylpolyglutamate synthetase-deficient, methotrexate-resistant CCRF-CEM human leukemia sublines.
    McGuire JJ, Heitzman KJ, Haile WH, Russell CA, McCloskey DE, Piper JR.
    Leukemia; 1993 Dec 02; 7(12):1996-2003. PubMed ID: 8255099
    [Abstract] [Full Text] [Related]

  • 25. Sequential amplification of dihydrofolate reductase and multidrug resistance genes in Chinese hamster ovary cells selected for stepwise resistance to the lipid-soluble antifolate trimetrexate.
    Assaraf YG, Molina A, Schimke RT.
    J Biol Chem; 1989 Nov 05; 264(31):18326-34. PubMed ID: 2572592
    [Abstract] [Full Text] [Related]

  • 26. Folate requirements of methotrexate-resistant human acute lymphoblastic leukemia cell lines.
    Kano Y, Ohnuma T, Holland JF.
    Blood; 1986 Aug 05; 68(2):586-91. PubMed ID: 2942201
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Quinoxaline chemistry. Part 9. Quinoxaline analogues of trimetrexate (TMQ) and 10-propargyl-5,8-dideazafolic acid (CB 3717) and its precursors. Synthesis and evaluation of in vitro anticancer activity.
    Loriga M, Vitale G, Paglietti G.
    Farmaco; 1998 Feb 05; 53(2):139-49. PubMed ID: 9604321
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Characterization of trimetrexate transport in human lymphoblastoid cells and development of impaired influx as a mechanism of resistance to lipophilic antifolates.
    Fry DW, Besserer JA.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):6986-91. PubMed ID: 2973370
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems.
    Westerhof GR, Jansen G, van Emmerik N, Kathmann I, Rijksen G, Jackman AL, Schornagel JH.
    Cancer Res; 1991 Oct 15; 51(20):5507-13. PubMed ID: 1655252
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
    Westerhof GR, Schornagel JH, Kathmann I, Jackman AL, Rosowsky A, Forsch RA, Hynes JB, Boyle FT, Peters GJ, Pinedo HM.
    Mol Pharmacol; 1995 Sep 15; 48(3):459-71. PubMed ID: 7565626
    [Abstract] [Full Text] [Related]

  • 38. The influence of drug-exposure conditions on the development of resistance to methotrexate or ZD1694 in cultured human leukaemia cells.
    Takemura Y, Kobayashi H, Gibson W, Kimbell R, Miyachi H, Jackman AL.
    Int J Cancer; 1996 Mar 28; 66(1):29-36. PubMed ID: 8608962
    [Abstract] [Full Text] [Related]

  • 39. Large diversity in transport-mediated methotrexate resistance in human leukemia cell line CCRF-CEM established in a high concentration of leucovorin.
    Asai S, Miyachi H, Kobayashi H, Takemura Y, Ando Y.
    Cancer Sci; 2003 Feb 28; 94(2):210-4. PubMed ID: 12708499
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.